ArticleFrontiers in oncology2026
An interpretable multimodal machine learning model integrating transvaginal ultrasound and clinical features for differentiating benign from malignant endometrial thickening in postmenopausal women.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate an interpretable multimodal machine learning model that integrates transvaginal ultrasound (TVUS) deep learning features with clinical risk factors for differentiating benign from malignant endometrial thickening in postmenopausal women, with the aim of reducing unnecessary invasive procedures. Methods: In this retrospective single-centre diagnostic study, 601 postmenopausal women with histopathologically confirmed endometrial thickening (509 benign, 92 malignant) were identified consecutively and allocated to a training set (n = 420) and a stratified held-out test set (n = 181) at a 7:3 ratio. Deep learning features were extracted from manually segmented mid-sagittal TVUS images via four pretrained ResNet architectures and compressed into a single imaging score (DL_score) through sequential mRMR filtering and LASSO regression. Independent clinical predictors were identified by multivariate logistic regression. Ten fusion classifiers were trained on the combined feature set and evaluated by AUC, calibration, decision curve analysis, and SHAP-based interpretability. Results: In the test set, all image-based models outperformed the clinical-only model (AUC, 0.797; 95% CI, 0.707-0.888), with ResNet152 achieving the highest single-modality AUC (0.850; 95% CI, 0.782-0.917). Among the combined models, logistic regression (LR) performed best, with an AUC of 0.906 (95% CI, 0.842-0.970), an accuracy of 84.6%, a sensitivity of 75.9%, and a specificity of 92.1%. The LR model was well calibrated (Brier score, 0.08; Hosmer-Lemeshow P = 0.60) and, on DCA, provided the greatest net benefit across the clinically relevant range of threshold probabilities. SHAP analysis identified the DL_score, postmenopausal bleeding, and BMI as the three most influential predictors; Grad-CAM activation maps indicated that the DL_score captured spatially localised information related to endometrial bulk and junction integrity. Conclusion: The combined image-clinical logistic regression model demonstrated promising discriminatory and calibration performance for risk stratification of postmenopausal endometrial thickening, achieving improved specificity over conventional thickness-based criteria. This interpretable multimodal approach may serve as a useful adjunct to support clinical decision-making in identifying postmenopausal women at lower risk of malignancy, potentially reducing the burden of unnecessary invasive procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.